U.S. Commercial Launch of ORLYNVAHTM by Q4 2025; First Oral Penem Available in the U.S. Management to host a conference call at ...

Zaynich is based on cefepime, a well-established beta-lactam antibiotic, combined with a novel beta-lactamase inhibitor ...

§ Faculty of Science, Health and Education, University of the Sunshine Coast, Maroochydore, DC, Queensland 4558, Australia, ∥ School of Population Health ...

The OxStu discusses the causes and implications of antimicrobial resistance, and the social and scientific methods to combat ...

O isolamento de bactérias produtoras de beta-lactamases de espectro expandido (ESBL ... and the transconjugant isolates were resistant to extended spectrum β-lactam antibiotics, these β-lactamases ...

Evidence of the impact of extended-spectrum beta-lactamase production on mortality and length ... Because estimates of clinical burden drive policy design for antibiotic stewardship and infection ...

In addition, antibiotic resistance is spread by the misuse of antibiotics ... caused by multiresistant klebsiella pneumoniae producing new delhi metallo-beta-lactamase (NDM-1) with strains genotyping.

Antibiotic-resistant infections are on the rise, threatening to make even common diseases deadly again. Without new antibiotics, experts warn that up to 100 million lives could be lost annually by ...

A rational design strategy was used to construct a sensitive “turn-on” biosensor for β-lactam antibiotics and β-lactamase inhibitors from a class A β-lactamase mutant with suppressed hydrolytic ...